Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and <i>in vivo</i> tumor growth of triple-negative breast cancer.

Cancer biology & therapy·2020
Same author

A seven-gene CpG-island methylation panel predicts breast cancer progression.

BMC cancer·2015
Same author

Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.

Cancer letters·2014
Same author

The prolyl peptidases PRCP/PREP regulate IRS-1 stability critical for rapamycin-induced feedback activation of PI3K and AKT.

The Journal of biological chemistry·2014
Same author

DNA methylation as clinically useful biomarkers-light at the end of the tunnel.

Pharmaceuticals (Basel, Switzerland)·2013
Same author

Molecular biomarkers in 2013.

Expert review of molecular diagnostics·2013

Related Experiment Video

Updated: May 28, 2026

Methylated DNA Immunoprecipitation
21:24

Methylated DNA Immunoprecipitation

Published on: January 2, 2009

The MethDet: a technology for biomarker development.

Victor V Levenson1, Anatoliy A Melnikov

  • 1Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA. victor_levenson@rush.edu

Expert Review of Molecular Diagnostics
|October 26, 2011
PubMed
Summary

This study introduces a novel platform technology for genome-wide DNA methylation analysis using minimal samples. This methylation detection (MethDet) technology enables early disease biomarker discovery and monitoring.

More Related Videos

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics
09:05

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

Published on: June 29, 2020

Methodology for Accurate Detection of Mitochondrial DNA Methylation
12:11

Methodology for Accurate Detection of Mitochondrial DNA Methylation

Published on: May 20, 2018

Related Experiment Videos

Last Updated: May 28, 2026

Methylated DNA Immunoprecipitation
21:24

Methylated DNA Immunoprecipitation

Published on: January 2, 2009

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics
09:05

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

Published on: June 29, 2020

Methodology for Accurate Detection of Mitochondrial DNA Methylation
12:11

Methodology for Accurate Detection of Mitochondrial DNA Methylation

Published on: May 20, 2018

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Early disease detection relies on biomarkers, necessitating robust development and validation methods.
  • Current methods may require substantial sample volumes, limiting accessibility for certain sample types.

Purpose of the Study:

  • To present a platform technology for genome-wide DNA methylation analysis from small sample volumes.
  • To enable early disease detection and monitoring through epigenetic profiling.

Main Methods:

  • Developed a methylation detection (MethDet) platform for genome-wide DNA methylation analysis.
  • Utilized small sample inputs: biopsy, formalin-fixed paraffin-embedded tissue sections, or 0.4 ml plasma.
  • Enabled genome-wide association studies comparable to single-nucleotide polymorphism analysis.

Main Results:

  • MethDet technology analyzes epigenetic changes, reflecting disease-dependent alterations in gene expression.
  • The assay effectively uses highly fragmented DNA, including cell-free circulating DNA from plasma.
  • Identified disease-specific changes, treatment effects, and disease activity variations.

Conclusions:

  • MethDet offers a powerful tool for genome-wide epigenetic analysis with minimal sample requirements.
  • This technology facilitates the discovery and validation of novel biomarkers for early disease detection.
  • MethDet can track disease progression, treatment response, and activity through epigenetic modifications.